NCT05250427

Brief Summary

ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor through existing databases/panels in APAC region. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,404

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
9 countries

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 22, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 26, 2022

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2022

Completed
Last Updated

June 14, 2022

Status Verified

June 1, 2022

Enrollment Period

27 days

First QC Date

February 11, 2022

Last Update Submit

June 13, 2022

Conditions

Outcome Measures

Primary Outcomes (7)

  • Weight loss motivators for improving health of PLwO

    Multi-select from defined list

    At the time of survey response (Day 1)

  • Weight loss barriers for improving health of PLwO

    Multi-select from defined list

    At the time of survey response (Day 1)

  • Weight loss management for improving health of PLwO

    Multi-select from defined list

    At the time of survey response (Day 1)

  • Weight loss responsibility for improving health of PLwO

    Multi-select from defined list

    At the time of survey response (Day 1)

  • Proportion of PLwO who made serious weight loss effort

    Number of weight loss efforts; percentage of patients

    At the time of survey response (Day 1)

  • Response to weight loss discussions

    Single select from defined list

    At the time of survey response (Day 1)

  • Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs

    5-point Likert scales

    At the time of survey response (Day 1)

Study Arms (2)

People / Person Living with Obesity (PLwO)

From online, general population consumer panels

Other: No treatment given

Health Care Professionals (HCPs)

HCPs treating people who have obesity

Other: No treatment given

Interventions

No treatment given

Health Care Professionals (HCPs)People / Person Living with Obesity (PLwO)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management.

You may qualify if:

  • People Living with Obesity
  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged above or equal to 18 years at the time of signing informed consent
  • Lives in one of the target countries
  • Current BMI of at least 25 kg/m\^2 for all countries (except Singapore which has current BMI 27 kg/m\^2) based on self-reported height and weight
  • Health Care Professionals
  • Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
  • Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
  • Physician
  • Primary Care Providers (PCPs) whose specialty is Family practice, General practice, Internal Medicine
  • Non-PCP Specialties whose specialty is Endocrinologist, Cardiologist, Gastroenterologist, Obstetrics/Gynaecologist, Bariatrics/Obesity Medicine, Nutrition Specialist (physician) Orthopaedist, Aesthetics Medicine
  • Specialty is not surgeon (including bariatric or plastic surgeon)
  • Practices in the target countries
  • In clinical practice for at least 2 years
  • Spends at least 50% time in direct patient care
  • +2 more criteria

You may not qualify if:

  • People Living with obesity
  • Previous participation in this study. Participation is defined as having given online consent in this study
  • Currently pregnant
  • Participates in intense fitness or body building programs
  • Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
  • Health Care Providers
  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Novo Nordisk Investigational Site

Dhaka, Bangladesh

Location

Novo Nordisk Investigational Site

Bangalore, India

Location

Novo Nordisk Investigational Site

Jakarta, Indonesia

Location

Novo Nordisk Investigational Site

Kuala Lumpur, Malaysia

Location

Novo Nordisk Investigational Site

Karachi, Pakistan

Location

Novo Nordisk Investigational Site

Manila, Philippines

Location

Novo Nordisk Investigational Site

Singapore, Singapore

Location

Novo Nordisk Investigational Site

Bangkok, Thailand

Location

Novo Nordisk Investigational Site

Ho Chi Minh City, Vietnam

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Clinical Transparency (dept. 2834)

    Novo Nordisk A/S

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2022

First Posted

February 22, 2022

Study Start

April 26, 2022

Primary Completion

May 23, 2022

Study Completion

May 23, 2022

Last Updated

June 14, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

More information

Locations